{
  "ptid_time": "116_S_4010_2011-06-30",
  "img_path": "/data/qiuhui/data/adni/images/116_S_4010/2011-06-30/t1.nii.gz",
  "img_finding": "Image findings: ventricular volume measures 31,817 mm³, 13.4% above the reference mean. With a Z-score of 0.31 (62.0th percentile), this represents normal volume ; hippocampal volume measures 5,796 mm³, 18.5% below the reference mean. With a Z-score of -1.70 (4.5th percentile), this represents moderate atrophy; whole brain volume measures 911,317 mm³, 6.5% below the reference mean. With a Z-score of -0.82 (20.7th percentile), this represents normal volume ; entorhinal cortex volume measures 3,892 mm³, 6.0% above the reference mean. With a Z-score of 0.37 (64.3th percentile), this represents normal volume ; fusiform gyrus volume measures 18,787 mm³, 10.4% above the reference mean. With a Z-score of 0.95 (82.9th percentile), this represents normal volume ; middle temporal gyrus volume measures 18,141 mm³, 5.4% below the reference mean. With a Z-score of -0.47 (32.1th percentile), this represents normal volume . ",
  "text_data": "Age is 70.8 years. Gender is Female. Education: 18 years. Handedness: Right. Race: White. Medical history: Psychiatric; Neurologic; Head, Eyes, Ears, Nose and Throat; Dermatologic-Connective Tissue; Musculoskeletal; Gastrointestinal; Renal-Genitourinary; Allergies or Drug Sensitivities; Major Surgical Procedures. MMSE: 29.0. MoCA: 25.0. Logical Memory: 19.0. APOEε4 alleles: 0.0. Biomarker levels: Florbetapir (AV45): 1.36 SUVR (significant elevated); Amyloid beta: 681.80 pg/mL (normal ); Total tau: 160.60 pg/mL (mild reduced); Phosphorylated tau: 14.52 pg/mL (normal ). ",
  "true_diagnosis": "Diagnosis: CN.",
  "gpt_diagnosis": "**Reasoning:** The hippocampal volume shows moderate atrophy (Z-score -1.70, 4.5th percentile), which is a strong biomarker for Alzheimer's pathology, while other brain regions are within normal ranges. Elevated AV45 (amyloid PET) suggests significant amyloid deposition, but cognitive scores (MMSE 29, MoCA 25) are near-normal with only subtle impairment.  \n**Diagnosis:** **Mild Cognitive Impairment (MCI)** (likely amyloid-positive, hippocampal-predominant neurodegeneration).  \n**Confidence:** **Medium** (cognitive scores are borderline, but biomarker profile supports early-stage pathology).  \n\n*Note: The discrepancy between preserved cognition and biomarker abnormalities suggests preclinical or very early MCI. Follow-up cognitive testing and monitoring progression would strengthen confidence.*",
  "timestamp": "2025-07-26T12:05:42.578912"
}